Bartlett & Co. LLC - DIREXION SHS ETF TR ownership

DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 20 filers reported holding DIREXION SHS ETF TR in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bartlett & Co. LLC ownership history of DIREXION SHS ETF TR
ValueSharesWeighting
Q4 2023$25
+13.6%
2450.0%0.00%
Q3 2023$22
-12.0%
2450.0%0.00%
Q2 2023$25
+4.2%
2450.0%0.00%
Q1 2023$24
-14.3%
2450.0%0.00%
-100.0%
Q4 2022$28
-99.9%
2450.0%0.00%
Q3 2022$21,000
-16.0%
2450.0%0.00%
-100.0%
Q2 2022$25,000
-21.9%
2450.0%0.00%0.0%
Q1 2022$32,0002450.00%
Other shareholders
DIREXION SHS ETF TR shareholders Q4 2022
NameSharesValueWeighting ↓
Bullseye Investment Management, LLC 51,862$4,591,3433.73%
Traynor Capital Management, Inc. 10,020$887,0890.11%
Onyx Bridge Wealth Group LLC 2,612$231,2030.05%
Covestor Ltd 203$180.01%
Tower Research Capital LLC (TRC) 1,603$141,9140.00%
Headlands Technologies LLC 58$5,1350.00%
GTS SECURITIES LLC 21,736$1,922,9500.00%
Quantbot Technologies LP 262$23,1950.00%
GOLDMAN SACHS GROUP INC 37,525$3,322,0880.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 37,700$3,337,5810.00%
View complete list of DIREXION SHS ETF TR shareholders